BARCLAYS PLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 67 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$9,000
-57.1%
2,407
-63.6%
0.00%
Q2 2021$21,000
-69.1%
6,607
-78.8%
0.00%
Q1 2021$68,000
+151.9%
31,094
+159.0%
0.00%
Q4 2020$27,000
-41.3%
12,006
-30.5%
0.00%
Q3 2020$46,000
-28.1%
17,280
-17.9%
0.00%
Q2 2020$64,000
+137.0%
21,051
+57.3%
0.00%
Q1 2020$27,000
-76.5%
13,382
-66.6%
0.00%
Q4 2019$115,000
+59.7%
40,060
+101.6%
0.00%
Q3 2019$72,000
-16.3%
19,872
-4.4%
0.00%
Q2 2019$86,000
-87.3%
20,788
-84.3%
0.00%
Q1 2019$677,000
+13.0%
132,391
-24.2%
0.00%
Q4 2018$599,000
+1518.9%
174,603
+2711.6%
0.00%
Q3 2018$37,000
+85.0%
6,210
+94.4%
0.00%
Q2 2018$20,000
-79.2%
3,194
-84.1%
0.00%
Q1 2018$96,000
+9500.0%
20,123
+3405.7%
0.00%
Q1 2015$1,000
-75.0%
574
-59.3%
0.00%
Q4 2014$4,000
+300.0%
1,411
+654.5%
0.00%
Q3 2014$1,000
-80.0%
187
-52.7%
0.00%
Q2 2014$5,000
+400.0%
395
+472.5%
0.00%
Q1 2014$1,000
-96.2%
69
-97.9%
0.00%
Q4 2013$26,000
+420.0%
3,300
+560.0%
0.00%
Q3 2013$5,0005000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders